FindTrial
Sign In

A retrospective study for risk factors of rebleeding and comparison between different hemostatic therapies in gastrointestinal bleeding patients with Forrest IIa ulcer

A retrospective study for risk factors of rebleeding and comparison between different hemostatic therapies in gastrointestinal bleeding patients with Forrest IIa ulcer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020146
Enrollment
Unknown
Registered
2018-12-17
Start date
2018-12-26
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peptic ulcer

Interventions

Combination group:Endoscopy + Radiological intervention
Endoscopy group:Endoscopy

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Acute gastrointestinal bleeding patients due to Forrest IIa ulcer

Exclusion criteria

Exclusion criteria: 1) did not receive any hemostatic therapy under endoscopy; 2) bore the endoscopic appearance of tumor, or were confirmed as tumor by pathology.

Design outcomes

Primary

MeasureTime frame
Rebleeding occurence and time ;—

Secondary

MeasureTime frame
ICU transmission, need of surgery, all-cause mortality, transfusion amount of red blood cell suspension and plasma, etc;—

Countries

China

Contacts

Public ContactHuan Tong

West China Hospital, Sichuan University

doctortonghuan@163.com+86 28 85422383

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026